Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from Northwest Spain

Journal of Rheumatology

Volumn 30, Issue 5, 2003, Pages 913-917

  Gonzalez Gay, Miguel A ^a,c   Hajeer, Ali H ^b   Garcia Porrua, Carlos ^a   Dababneh, Adele ^b   Amoli, Mahsa M ^b   Botana, Manuel A ^a   Thomson, Wendy ^b   Llorca, Javier ^a   Ollier, William E R ^b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HOSPITAL XERAL CALDE   (Spain)

Author keywords

Age of onset; CRH; Disease susceptibility; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; RHEUMATOID FACTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE CONTROL; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SPAIN;

AGE OF ONSET; ARTHRITIS, RHEUMATOID; CORTICOTROPIN-RELEASING HORMONE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SPAIN;

EID: 0038752861     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ollier WER, Hajeer AH. Does the HLA-DRB1 shared epitope really contribute that much to the development or severity of rheumatoid arthritis? In: Isenberg DA, Tucker LB, editors. Controversies in rheumatology. London: Martin Dunitz: 2000:1-12.
2. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. The HLA-DRB1 influence in the susceptibility and severity to rheumatoid arthritis. Semin Arthritis Rheum 2002;31:355-60.
3. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36:178-82.
4. Ollier WE, Harrison B, Symmons D. What is the natural history of rheumatoid arthritis? Baillieres Best Pract Res Clin Rheumatol 2001;15:27-48.
5. Foppiani L, Cutolo M, Sessarego P, et al. Desmopressin and low-dose ACTH test in rheumatoid arthritis. Eur J Endocrinol 1998;138:294-301.
6. Arbiser JL, Morton CC, Bruns GA, Majzoub JA. Human corticotropin releasing hormone gene is located on the long arm of chromosome 8. Cytogenet Cell Genet 1988;47:113-6.
7. Sternberg EM, Young WS 3rd, Bernardini R, et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771-5.
8. Baerwald CG, Panayi GS, Lanchbury JS. Corticotropin releasing hormone promoter region polymorphisms in rheumatoid arthritis. J Rheumatol 1997;24:215-6.
9. Fife MS, Fisher SA, John S, et al. Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis Rheum 2000;43:1673-8.
10. Baerwald CG, Mok CC, Tickly M, et al. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients with rheumatoid arthritis. Z Rheumatol 2000;59:29-34.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Healey LA. Rheumatoid arthritis in the elderly. Clin Rheum Dis North Am 1986;12:173-9.
13. Gonzalez-Gay MA, Hajeer AH, Garcia-Porrua C, et al. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset. J Rheumatol 2002;29:271-5.
14. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine Baltimore 2000;79:283-92.
15. Gonzalez-Gay MA, Hajeer AH, Dababneh A, et al. Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. J Rheumatol 2001;28:122-5.
16. Baerwald CG, Panayi GS, Lanchbury JS. A new XmnI polymorphism in the regulatory region of the corticotropin releasing hormone gene. Hum Genet 1996;97:697-8.
17. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991;43:425-73.
18. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS, Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
19. Gutierrez MA, Garcia ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999;26:277-81.
20. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
21. Hajeer AH, Dababneh A, Makki RF, et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 2000;55:319-25.
22. Gonzalez-Gay MA, Hajeer AH, Dababneh A, et al. Corticotropin releasing hormone promoter polymorphism in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 2002;20:133-8.
23. Healey LA. Polymyalgic rheumatica and seronegative rheumatoid arthritis may be the same entity. J Rheumatol 1992;19:270-2.